NovoCure Ltd — Director's Dealing 2015

Dec 22, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-12-21

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-21	Ordinary Shares	M	1100	$0.17	Acquired	1100	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-21	Options to Buy Ordinary Shares	$0.17	M	1100	Disposed	2016-07-01	Ordinary Shares (334084)	Direct

Footnotes

F1: Fully vested and currently exercisable as of the date hereof.